Linking high-sensitivity C-reactive protein and dyslipidemia among patients with type 2 diabetes mellitus.

IF 1.9
Bioinformation Pub Date : 2025-06-30 eCollection Date: 2025-01-01 DOI:10.6026/973206300211357
Ramesh Dnyandeo Kurle, Veluri Ganesh, Dileep Khubya, Gadigeppa H Chittaragi
{"title":"Linking high-sensitivity C-reactive protein and dyslipidemia among patients with type 2 diabetes mellitus.","authors":"Ramesh Dnyandeo Kurle, Veluri Ganesh, Dileep Khubya, Gadigeppa H Chittaragi","doi":"10.6026/973206300211357","DOIUrl":null,"url":null,"abstract":"<p><p>Type 2 diabetes is evaluated in a condition elevated hs-CRP is linked to an increased risk of myocardial infraction development. Therefore, it is of interest to evaluate the hs-CRP in patients with type 2 diabetes mellitus who were not diagnosed with hypertension. We included total 120 T2DM patients attended to general medicine department and 60 healthy controls also included in the case control study. We measured demographic, anthropometric and clinical parameters from all the subjects. The type 2 diabetes mellitus patients with hypertension who had increased hs-CRP levels had a greater incidence of myocardial infraction results death and morbidity when compared to type 2 diabetes mellitus patients without hypertension. We show that CRP is a strong predictor of hospital morbidity and mortality in patients with acute myocardial infarction who have diabetes with hypertension as well as those who do not have hypertension.</p>","PeriodicalId":8962,"journal":{"name":"Bioinformation","volume":"21 6","pages":"1357-1361"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12449554/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioinformation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6026/973206300211357","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Type 2 diabetes is evaluated in a condition elevated hs-CRP is linked to an increased risk of myocardial infraction development. Therefore, it is of interest to evaluate the hs-CRP in patients with type 2 diabetes mellitus who were not diagnosed with hypertension. We included total 120 T2DM patients attended to general medicine department and 60 healthy controls also included in the case control study. We measured demographic, anthropometric and clinical parameters from all the subjects. The type 2 diabetes mellitus patients with hypertension who had increased hs-CRP levels had a greater incidence of myocardial infraction results death and morbidity when compared to type 2 diabetes mellitus patients without hypertension. We show that CRP is a strong predictor of hospital morbidity and mortality in patients with acute myocardial infarction who have diabetes with hypertension as well as those who do not have hypertension.

2型糖尿病患者高敏c反应蛋白与血脂异常的关系
2型糖尿病是在hs-CRP升高与心肌梗死发展风险增加相关的情况下评估的。因此,评估未诊断为高血压的2型糖尿病患者hs-CRP具有重要意义。我们纳入了在普通内科就诊的120例T2DM患者和60例健康对照者,也纳入了病例对照研究。我们测量了所有受试者的人口学、人体测量学和临床参数。与无高血压的2型糖尿病患者相比,伴有hs-CRP水平升高的2型糖尿病合并高血压患者心肌梗死、死亡和发病率的发生率更高。我们发现CRP是急性心肌梗死合并糖尿病合并高血压患者和无高血压患者住院发病率和死亡率的一个强有力的预测因子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioinformation
Bioinformation MATHEMATICAL & COMPUTATIONAL BIOLOGY-
自引率
0.00%
发文量
128
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信